CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 109 of 865
Non-Antibody Products
Page 109 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| BMS 502 | An inhibitor of DGK-α, DGK-ζ, and DGK-ι; (IC50s = 0.0046,… | 5 mg | 39303-5 | More Info |
| BMS 502 | An inhibitor of DGK-α, DGK-ζ, and DGK-ι; (IC50s = 0.0046,… | 50 mg | 39303-50 | More Info |
| BMS 582949 | A p38α MAP kinase inhibitor (IC50 = 13 nM); inhibits TNF-α pro… | 1 mg | 22892-1 | More Info |
| BMS 582949 | A p38α MAP kinase inhibitor (IC50 = 13 nM); inhibits TNF-α pro… | 25 mg | 22892-25 | More Info |
| BMS 582949 | A p38α MAP kinase inhibitor (IC50 = 13 nM); inhibits TNF-α pro… | 5 mg | 22892-5 | More Info |
| BMS 626529 | An HIV-1 attachment inhibitor; binds to non-ligand bound HIV-1 gp120 to in… | 1 mg | 18413-1 | More Info |
| BMS 626529 | An HIV-1 attachment inhibitor; binds to non-ligand bound HIV-1 gp120 to in… | 10 mg | 18413-10 | More Info |
| BMS 626529 | An HIV-1 attachment inhibitor; binds to non-ligand bound HIV-1 gp120 to in… | 5 mg | 18413-5 | More Info |
| BMS 626529 | An HIV-1 attachment inhibitor; binds to non-ligand bound HIV-1 gp120 to in… | 50 mg | 18413-50 | More Info |
| BMS 663068 | A prodrug form of BMS 626529 | 1 mg | 37708-1 | More Info |
| BMS 663068 | A prodrug form of BMS 626529 | 10 mg | 37708-10 | More Info |
| BMS 663068 | A prodrug form of BMS 626529 | 25 mg | 37708-25 | More Info |
| BMS 663068 | A prodrug form of BMS 626529 | 5 mg | 37708-5 | More Info |
| BMS 687453 | A potent PPARα agonist (EC50 = 10 nM in a transactivation assay usin… | 1 mg | 19404-1 | More Info |
| BMS 687453 | A potent PPARα agonist (EC50 = 10 nM in a transactivation assay usin… | 10 mg | 19404-10 | More Info |
| BMS 687453 | A potent PPARα agonist (EC50 = 10 nM in a transactivation assay usin… | 25 mg | 19404-25 | More Info |
| BMS 687453 | A potent PPARα agonist (EC50 = 10 nM in a transactivation assay usin… | 5 mg | 19404-5 | More Info |
| BMS 753 | A synthetic retinoid and RARα agonist (Ki = 2 nM); selective for RAR… | 1 mg | 29493-1 | More Info |
| BMS 753 | A synthetic retinoid and RARα agonist (Ki = 2 nM); selective for RAR… | 10 mg | 29493-10 | More Info |
| BMS 753 | A synthetic retinoid and RARα agonist (Ki = 2 nM); selective for RAR… | 5 mg | 29493-5 | More Info |
| BMS 754807 | A reversible, orally bioavailable dual inhibitor of IGF-1R and InsR tyrosi… | 1 mg | 17505-1 | More Info |
| BMS 754807 | A reversible, orally bioavailable dual inhibitor of IGF-1R and InsR tyrosi… | 10 mg | 17505-10 | More Info |
| BMS 754807 | A reversible, orally bioavailable dual inhibitor of IGF-1R and InsR tyrosi… | 5 mg | 17505-5 | More Info |
| BMS 779788 | A partial agonist of LXRα and LXRβ (Kis = 68 and 14 nM, respect… | 1 mg | 27339-1 | More Info |
| BMS 779788 | A partial agonist of LXRα and LXRβ (Kis = 68 and 14 nM, respect… | 10 mg | 27339-10 | More Info |
| BMS 779788 | A partial agonist of LXRα and LXRβ (Kis = 68 and 14 nM, respect… | 5 mg | 27339-5 | More Info |
| BMS 794833 | An inhibitor of c-Met and VEGFR2 (IC50s = 1.7 and 15 nM, respectively); in… | 1 mg | 26180-1 | More Info |
| BMS 794833 | An inhibitor of c-Met and VEGFR2 (IC50s = 1.7 and 15 nM, respectively); in… | 10 mg | 26180-10 | More Info |
| BMS 794833 | An inhibitor of c-Met and VEGFR2 (IC50s = 1.7 and 15 nM, respectively); in… | 25 mg | 26180-25 | More Info |
| BMS 794833 | An inhibitor of c-Met and VEGFR2 (IC50s = 1.7 and 15 nM, respectively); in… | 5 mg | 26180-5 | More Info |
| BMS 813160 | A dual antagonist of CCR2 and CCR5 (IC50s = 6.2 and 3.6 nM, respectively,… | 1 mg | 28421-1 | More Info |
| BMS 813160 | A dual antagonist of CCR2 and CCR5 (IC50s = 6.2 and 3.6 nM, respectively,… | 5 mg | 28421-5 | More Info |
| BMS 833923 | An orally bioavailable inhibitor of Smo; blocks binding of BODIPY cyclopam… | 10 mg | 16240-10 | More Info |
| BMS 833923 | An orally bioavailable inhibitor of Smo; blocks binding of BODIPY cyclopam… | 25 mg | 16240-25 | More Info |
| BMS 833923 | An orally bioavailable inhibitor of Smo; blocks binding of BODIPY cyclopam… | 5 mg | 16240-5 | More Info |
| BMS 833923 | An orally bioavailable inhibitor of Smo; blocks binding of BODIPY cyclopam… | 50 mg | 16240-50 | More Info |
| BMS 986020 | An LPA1 receptor antagonist (Kb = 0.0067 µM); selective for LPA1 ove… | 1 mg | 22049-1 | More Info |
| BMS 986020 | An LPA1 receptor antagonist (Kb = 0.0067 µM); selective for LPA1 ove… | 5 mg | 22049-5 | More Info |
| BMS 986020 | An LPA1 receptor antagonist (Kb = 0.0067 µM); selective for LPA1 ove… | 500 µg | 22049-500 | More Info |
| BMS 986120 | A selective PAR4 antagonist (IC50 = 0.56 nM); selective for PAR4 over PAR1… | 1 mg | 23497-1 | More Info |
| BMS 986120 | A selective PAR4 antagonist (IC50 = 0.56 nM); selective for PAR4 over PAR1… | 10 mg | 23497-10 | More Info |
| BMS 986120 | A selective PAR4 antagonist (IC50 = 0.56 nM); selective for PAR4 over PAR1… | 5 mg | 23497-5 | More Info |
| BMS 986122 | A positive allosteric modulator of μ-opioid receptors (EC50 = 3 µ… | 1 mg | 23269-1 | More Info |
| BMS 986122 | A positive allosteric modulator of μ-opioid receptors (EC50 = 3 µ… | 5 mg | 23269-5 | More Info |
| BMS 986142 | A BTK inhibitor (IC50 = 0.5 nM); greater than 20-fold selective for BTK ov… | 1 mg | 30927-1 | More Info |
| BMS 986142 | A BTK inhibitor (IC50 = 0.5 nM); greater than 20-fold selective for BTK ov… | 5 mg | 30927-5 | More Info |
| BMS 986142 | A BTK inhibitor (IC50 = 0.5 nM); greater than 20-fold selective for BTK ov… | 500 µg | 30927-500 | More Info |
| BMS 986158 | A BET bromodomain inhibitor; decreases c-Myc expression and induces cancer… | 1 mg | 27789-1 | More Info |
| BMS 986158 | A BET bromodomain inhibitor; decreases c-Myc expression and induces cancer… | 10 mg | 27789-10 | More Info |
| BMS 986158 | A BET bromodomain inhibitor; decreases c-Myc expression and induces cancer… | 25 mg | 27789-25 | More Info |
| BMS 986158 | A BET bromodomain inhibitor; decreases c-Myc expression and induces cancer… | 5 mg | 27789-5 | More Info |
| BMS 986165 | An allosteric inhibitor of TYK2 (IC50 = 0.2 nM for the recombinant TYK2 ps… | 1 mg | 33524-1 | More Info |
| BMS 986165 | An allosteric inhibitor of TYK2 (IC50 = 0.2 nM for the recombinant TYK2 ps… | 10 mg | 33524-10 | More Info |
| BMS 986165 | An allosteric inhibitor of TYK2 (IC50 = 0.2 nM for the recombinant TYK2 ps… | 25 mg | 33524-25 | More Info |
| BMS 986165 | An allosteric inhibitor of TYK2 (IC50 = 0.2 nM for the recombinant TYK2 ps… | 5 mg | 33524-5 | More Info |
| BMS 986187 | A positive allosteric modulator of δ-opioid receptors; has an averag… | 1 mg | 21549-1 | More Info |
| BMS 986187 | A positive allosteric modulator of δ-opioid receptors; has an averag… | 10 mg | 21549-10 | More Info |
| BMS 986187 | A positive allosteric modulator of δ-opioid receptors; has an averag… | 5 mg | 21549-5 | More Info |
| BMS 986188 | A positive allosteric modulator of δ-opioid receptors (EC50 = 0.05 &… | 1 mg | 21548-1 | More Info |
| BMS 986188 | A positive allosteric modulator of δ-opioid receptors (EC50 = 0.05 &… | 10 mg | 21548-10 | More Info |
| BMS 986188 | A positive allosteric modulator of δ-opioid receptors (EC50 = 0.05 &… | 5 mg | 21548-5 | More Info |
| BMS 986205 | An inhibitor of IDO1 (IC50 = 50s = 1.1 and 1.7 nM, respectively) | 1 mg | 25025-1 | More Info |
| BMS 986205 | An inhibitor of IDO1 (IC50 = 50s = 1.1 and 1.7 nM, respectively) | 10 mg | 25025-10 | More Info |
| BMS 986205 | An inhibitor of IDO1 (IC50 = 50s = 1.1 and 1.7 nM, respectively) | 25 mg | 25025-25 | More Info |
| BMS 986205 | An inhibitor of IDO1 (IC50 = 50s = 1.1 and 1.7 nM, respectively) | 5 mg | 25025-5 | More Info |
| BMS-265246 | A cell-permeable inhibitor of Cdk1 / cyclin B and Cdk2 / cyclin E (IC50s =… | 1 mg | 19168-1 | More Info |
| BMS-265246 | A cell-permeable inhibitor of Cdk1 / cyclin B and Cdk2 / cyclin E (IC50s =… | 5 mg | 19168-5 | More Info |
| BMS-299897 | A γ-secretase inhibitor; selectively cleaves APP CTF over Notch-1 CT… | 1 mg | 35777-1 | More Info |
| BMS-299897 | A γ-secretase inhibitor; selectively cleaves APP CTF over Notch-1 CT… | 10 mg | 35777-10 | More Info |
| BMS-299897 | A γ-secretase inhibitor; selectively cleaves APP CTF over Notch-1 CT… | 25 mg | 35777-25 | More Info |
| BMS-299897 | A γ-secretase inhibitor; selectively cleaves APP CTF over Notch-1 CT… | 5 mg | 35777-5 | More Info |
| BMS-3 | A potent inhibitor of activated LIMK1 and LIMK2 (IC50s = 5 and 6 nM, respe… | 1 mg | 19421-1 | More Info |
| BMS-3 | A potent inhibitor of activated LIMK1 and LIMK2 (IC50s = 5 and 6 nM, respe… | 10 mg | 19421-10 | More Info |
| BMS-3 | A potent inhibitor of activated LIMK1 and LIMK2 (IC50s = 5 and 6 nM, respe… | 25 mg | 19421-25 | More Info |
| BMS-3 | A potent inhibitor of activated LIMK1 and LIMK2 (IC50s = 5 and 6 nM, respe… | 5 mg | 19421-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile